You are here: Industry Insights > COVID-19

News List

Johnson & Johnson COVID-19 vaccine named one of Time's Best Inventions of 2021 WorldPharmaNews
November 15, 2021
The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021.
EMA endorses two monoclonal antibody medicines for COVID-19 EuropeanPharmaceuticalReview
November 15, 2021
The European Medicines Agency (EMA)’s human medicines committee, the Committee for Medicinal Products for Human Use (CHMP), has recommended authorising Ronapreve™ ...
The Lancet publishes Bharat Biotech’s Covaxin phase-III data ExpressPharma
November 15, 2021
Bharat Biotech today announced that the safety and efficacy analysis data from phase-III clinical trials of Covaxin is peer-reviewed and published in The Lancet, the company said in a statement.
EMA CHMP recommends authorisation of Roche-Regeneron’s Covid-19 therapy Pharmaceutical-Technology
November 15, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the EU approval of Roche and Regeneron’s Ronapreve...
Global Bioethanol Yeast Market Report (2021 to 2028) - Size, Share & Trends Analysis Report prnewswire
November 15, 2021
The "Bioethanol Yeast Market Size, Share & Trends Analysis Report By Product Type (Baker's, Brewer's), By Application (Cleaning & Disinfection, Biofuel), By Region (North America, MEA)...
Banty's Dr. Richard Tytus Explains How to Maintain a Strong Telemedicine Presence for Years to Come prnewswire
November 15, 2021
As COVID-19 continues to grip certain regions of the world, doctors are turning to telemedicine as a way to see patients, when possible, from a safe distance.
New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability AmericanPharmaceuticalReview
November 12, 2021
Anavasi Diagnostics, a medical technology company focused on the development of novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology...
CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease WorldPharmaNews
November 12, 2021
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of the antibody...
Valneva to supply Covid-19 vaccine doses to EU Pharmaceutical-Business-Review
November 12, 2021
French company Valneva has received European Commission (EC) approval for an agreement to supply the company’s inactivated Covid-19 vaccine candidate, VLA2001.
Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, Upon Authorization or Approval AmericanPharmaceuticalReview
November 12, 2021
Merck and Ridgeback Biotherapeutics announced that the Japanese government will purchase, upon authorization or approval, approximately 1.6 million courses of molnupiravir (MK-4482, EIDD-2801)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page